Michael J. Kadan

机构：Biomed Research Institute, Lentigen Technology (United States)

发表论文 24 篇 · 总被引 1184 次 · h-index 12

代表论文

Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial (2020 · Nature Medicine · 被引 467)
Intraocular expression of endostatin reduces VEGF‐induced retinal vascular permeability, neovascularization, and retinal detachment (2003 · The FASEB Journal · 被引 131)
Sustained Phenotypic Correction of Murine Hemophilia A by In Vivo Gene Therapy (1998 · Blood · 被引 106)
Factors Affecting Retroviral Vector Function and Structural Integrity (1993 · Virology · 被引 85)
Multiple site place-of-care manufactured anti-CD19 CAR-T cells induce high remission rates in B-cell malignancy patients (2021 · Nature Communications · 被引 80)
Optimization of the Generation and Propagation of Gutless Adenoviral Vectors (2003 · Human Gene Therapy · 被引 74)